John Maraganore
Dr. John Maraganore is an advisor to Evox. From 2002 through 2021, John served as the founding CEO of Alnylam Pharmaceuticals and brought the first RNAi drugs to the market. He currently sits on multiple biotech Boards and served as Chair of BIO from 2017 to 2019. He obtained his PhD from the University of Chicago.